The Oswaldo Cruz Foundation (Fiocruz) is the most prominent Institution of Science and Technology in Health in Latin America.
Its collaborative and open access Hub at TGHN aims to strengthen networks and improve capacities for public health research regionally and globally, by providing a vibrant virtual environment where professionals, students and researchers can share experiences, knowledge, resources and research tools.
Fiocruz is affiliated to the Brazilian Ministry of Health, and its mission is to produce, disseminate and share knowledge and technologies, aiming at strengthening and consolidating the Unified Health System (SUS, acronym in Portuguese for the Brazilian public health system) and the promotion of health and quality of life for the population.
Here, you can benefit from Fiocruz expertise in education to access the e-learning courses that have qualified over 1,8 million Brazilian health professionals. You also find publications with the most recent research findings, as well as information and news about Fiocruz.
Since 2015 Brazil has experienced the social repercussions of the Zika virus epidemic, thus raising a debate about: difficulties of diagnosis; healthcare access for children with Zika Congenital Syndrome (ZCS); ...
Coronavirus disease 2019 (COVID-19) is caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The impacts of the disease may be beyond the respiratory system, also affecting mental health. ...
Epidemics occur within the existing ecosystem of socioeconomic determinants of health, including class, gender, race, income, employment and individuals’ physical environment. The Zika virus epidemic (2014–2017) demonstrated disproportionate effects of ...
Abstract Data is becoming ever more critical and valuable for both scientists and health authorities searching for answers to the COVID-19 crisis. Due to difficulties in diagnosing this infection in ...
The 2015 to 2017 outbreak of Zika generated global attention on the risk of a spectrum of neurological disorders posed to women and their unborn children—including, but not limited to, ...
Abstract Background Science studies have been a field of research for different knowledge areas, and they have been successfully used to analyse the construction of scientific knowledge, practice and dissemination. ...
On March 11th, 2020, the World Health Organization (WHO) declared COVID-19 (the disease caused by the novel coronavirus SARS-CoV-2) a pandemic. As of this article's writing, more than 1.3 million ...
The emergence of Zika virus in 2015 challenged conventional ideas of mosquito-borne diseases, tested the resilience of health systems and embedded itself within local sociocultural worlds, with major implications for ...
The global spread of the 2019-nCoV is continuing and is fast moving, as indicated by the WHO raising the risk assessment to high. In this article, we provide a preliminary ...
Debate Cycle: COVID-19 6-month Pandemic Balance in Brazil
HEALTH SYSTEM, SOCIETY AND VULNERABILITIES
The Fiocruz COVID-19 Observatory organized a cycle of debates to discuss how Brazil responded to the pandemic and ways forward.
All webinars will have English simultaneous translation.
Click on the event title to watch!
Programme:
Sept 9: Epidemiological scenarios of COVID-19 in Brazil: impact evaluation and what´s next
Sept 17: Covid-19 - Challenges for Patient Security
Sept 23: Covid-19 and Social Repercussions: Narratives and evidence on inequalities and vulnerabilities in Brazil
Sept 30: The Covid-19 pandemic: Interfaces between populations, health systems and social inequalities
Saiba mais sobre a parceria Fiocruz+Universidade de Oxford para a produção de uma vacina contra a COVID-19
21/08/2020 Bio-Manguinhos/Fiocruz Through its Immunobiological Technology Institute in (Bio-Manguinhos/Fiocruz), the Oswaldo Cruz Foundation is now supplying trastuzumab to the Ministry of Health (MoH), which provides it to cancer patients free of cost through the Brazilian Public Health System (SUSm in ... Read more
30/07/2020 Fiocruz Bahia Chikungunya is a disease caused by a virus, which is transmitted through the bite of the Aedes aegypti mosquito, which may cause symptoms like fever, skin rashes and body pain. According to the Ministry of Health, from ... Read more
Maíra Menezes (IOC/Fiocruz) The Laboratory for Respiratory Viruses and Measles of the Oswaldo Cruz Institute (IOC/Fiocruz) has been nominated Reference Laboratory of the World Health Organization (WHO) for Covid-19 in the Americas. After the formalization of the agreement between the ... Read more
27/07/2020 Icict/Fiocruz Going back to school may represent an extra risk for more than 9.3 million Brazilians (4.4% of the overall population) who are elderly or adults (18 years and up) with chronic health conditions and at risk for Covid-19 ... Read more
03/08/2020 Filipe Leonel (Ensp) e Julia Dias (CCS) Researchers from the Oswaldo Cruz Foundation develop a plan to support the fight against Covid-19 among indigenous peoples. One of the goals is to intensify surveillance and improve information about the impacts ... Read more
Understanding the gendered dimensions of - COVID-19 - #InFocus
Watch the webinar in English
12/06/2020 Fiocruz The Institute of Technology in Immunobiological Products (Bio-Manguinhos/Fiocruz) is running a Brazilian project to develop a synthetic vaccine against the novel coronavirus (SARS-CoV-2). The studies are now advancing to a pre-clinical phase, in which safety aspects will be ... Read more
02/06/2020 Maíra Menezes (IOC/Fiocruz) Researchers of the Oswaldo Cruz Institute (IOC/Fiocruz), in a partnership with the University College London, in the United Kingdom, have developed a new protocol for the genetic sequencing of the novel coronavirus, the SARS-CoV-2. The methodology ... Read more
Fiocruz researcher Gustavo Matta says "COVID deaths are not numbers"
WATCH (In portuguese)
Follow the Fiocruz response and Brazilian actions and numbers regarding the COVID-19 pandemic.
Go to page
Available in English and Portuguese
The course presents general concepts of yellow fever, aimed at health professionals who work in primary healthcare. At the end of this course, you will be able to:
